Open·Ingested 279 days ago, not re-verified since

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

National Institutes of Health

Apply at National Institutes of Health

Free. Verify your email, then we send one reminder only.

Posted: Oct 23, 2025
Amount: $1,000,000
Closes: Oct 9, 2026 (in 71 days)

Similar opportunities open now

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses in 71 days
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)OpenNational Institutes of HealthCloses in 84 days
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 82 daysUp to $750K
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses in 62 days

Classification and identifiers

Solicitation number: RFA-DK-27-121
Assistance listing (CFDA): 93.847

Amount

$1,000,000

Who can apply

Tribal organizationsPublic universitiesNonprofits (non-501c3)Local governmentsPrivate universitiesCounty governments

Public colleges and universities, Local government agencies, and Private colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

About this opportunity

This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifesty...